Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William A Schmalhofer

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Channels (Austin, Tex.)|December 15, 2010
A KV2.1 gating modifier binding assay suitable for high throughput screeningWilliam A Schmalhofer, Kevin S Ratliff, Adam Weinglass, et al.
Biochemistry|April 23, 2003
Di-substituted cyclohexyl derivatives bind to two identical sites with positive cooperativity on the voltage-gated potassium channel, K(v)1.3William A Schmalhofer, Robert S Slaughter, Mary Matyskiela, et al.
Assay and Drug Development Technologies|December 17, 2010
A pharmacologically validated, high-capacity, functional thallium flux assay for the human Ether-à-go-go related gene potassium channelWilliam A Schmalhofer, Andrew M Swensen, Brande S Thomas, et al.
Molecular Pharmacology|August 30, 2008
ProTx-II, a selective inhibitor of NaV1.7 sodium channels, blocks action potential propagation in nociceptorsWilliam A Schmalhofer, Jeffrey Calhoun, Rachel Burrows, et al.
Biochemistry|July 27, 2005
Role of the C-terminus of the high-conductance calcium-activated potassium channel in channel structure and functionWilliam A Schmalhofer, Manuel Sanchez, Ge Dai, et al.
Biochemistry|August 16, 2006
Characterization of Kir1.1 channels with the use of a radiolabeled derivative of tertiapinJohn P Felix, Jessica Liu, William A Schmalhofer, et al.
Molecular Pharmacology|January 14, 2012
Selective, direct activation of high-conductance, calcium-activated potassium channels causes smooth muscle relaxationCristiano G Ponte, Owen B McManus, William A Schmalhofer, et al.
Bioorganic & Medicinal Chemistry Letters|May 10, 2005
Discovery of potent and use-dependent sodium channel blockers for treatment of chronic painJun Liang, Richard M Brochu, Charles J Cohen, et al.
Bioorganic & Medicinal Chemistry Letters|March 20, 2003
Benzamide derivatives as blockers of Kv1.3 ion channelShouwu Miao, Jianming Bao, Maria L Garcia, et al.
Biochemistry|June 12, 2002
Identification of a new class of inhibitors of the voltage-gated potassium channel, Kv1.3, with immunosuppressant propertiesWilliam A Schmalhofer, Jianming Bao, Owen B McManus, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Channels (Austin, Tex.)|December 15, 2010
A KV2.1 gating modifier binding assay suitable for high throughput screeningWilliam A Schmalhofer, Kevin S Ratliff, Adam Weinglass, et al.
Biochemistry|April 23, 2003
Di-substituted cyclohexyl derivatives bind to two identical sites with positive cooperativity on the voltage-gated potassium channel, K(v)1.3William A Schmalhofer, Robert S Slaughter, Mary Matyskiela, et al.
Assay and Drug Development Technologies|December 17, 2010
A pharmacologically validated, high-capacity, functional thallium flux assay for the human Ether-à-go-go related gene potassium channelWilliam A Schmalhofer, Andrew M Swensen, Brande S Thomas, et al.
Molecular Pharmacology|August 30, 2008
ProTx-II, a selective inhibitor of NaV1.7 sodium channels, blocks action potential propagation in nociceptorsWilliam A Schmalhofer, Jeffrey Calhoun, Rachel Burrows, et al.
Biochemistry|July 27, 2005
Role of the C-terminus of the high-conductance calcium-activated potassium channel in channel structure and functionWilliam A Schmalhofer, Manuel Sanchez, Ge Dai, et al.
Biochemistry|August 16, 2006
Characterization of Kir1.1 channels with the use of a radiolabeled derivative of tertiapinJohn P Felix, Jessica Liu, William A Schmalhofer, et al.
Molecular Pharmacology|January 14, 2012
Selective, direct activation of high-conductance, calcium-activated potassium channels causes smooth muscle relaxationCristiano G Ponte, Owen B McManus, William A Schmalhofer, et al.
Bioorganic & Medicinal Chemistry Letters|May 10, 2005
Discovery of potent and use-dependent sodium channel blockers for treatment of chronic painJun Liang, Richard M Brochu, Charles J Cohen, et al.
Bioorganic & Medicinal Chemistry Letters|March 20, 2003
Benzamide derivatives as blockers of Kv1.3 ion channelShouwu Miao, Jianming Bao, Maria L Garcia, et al.
Biochemistry|June 12, 2002
Identification of a new class of inhibitors of the voltage-gated potassium channel, Kv1.3, with immunosuppressant propertiesWilliam A Schmalhofer, Jianming Bao, Owen B McManus, et al.
Pageof 2